Contact this trialFirst, we need to learn more about you.
Stem Cell Transplant Agent
Vedolizumab Post-Stem Cell Transplant for Crohn's Disease
Recruiting3 awardsPhase 2
New York, New York
This trial is testing whether the drug Vedolizumab can help improve remission for Crohn's Disease patients who have had a hematopoietic stem cell transplant.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service